These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3698687)

  • 1. Random donor platelet cross-matching.
    Freedman J
    Curr Stud Hematol Blood Transfus; 1986; (52):65-70. PubMed ID: 3698687
    [No Abstract]   [Full Text] [Related]  

  • 2. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility.
    Lane D; Shivji S; Turner AR
    Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet crossmatching with Capture P: clinical relevance.
    Böck M; Heim MU; Schleich I; Weindler R; Wagner M; Mempel W
    Infusionstherapie; 1989 Aug; 16(4):183-5. PubMed ID: 2807565
    [No Abstract]   [Full Text] [Related]  

  • 5. First results with Capture-P, a solid phase immunoassay for the detection of platelet antibodies.
    Mayr WR; de Wit M; Gassner H; Hahn M; Goertz-Kaiser B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):459-61. PubMed ID: 2480290
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing.
    Rachel JM; Summers TC; Sinor LT; Plapp FV
    Am J Clin Pathol; 1988 Jul; 90(1):63-8. PubMed ID: 3389344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: platelet matching for alloimmunized patients--room for improvement.
    Nance ST; Hsu S; Vassallo RR; Murphy S
    Immunohematology; 2004; 20(2):80-8. PubMed ID: 15373656
    [No Abstract]   [Full Text] [Related]  

  • 8. HPA-1, 3, 5 genotyping to establish a typed platelet donor panel.
    Verran J; Grey D; Bennett J; Lown JA; Erber WN
    Pathology; 2000 May; 32(2):89-93. PubMed ID: 10840826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective platelet crossmatching for selection of compatible random donors.
    Freedman J; Hooi C; Garvey MB
    Br J Haematol; 1984 Jan; 56(1):9-18. PubMed ID: 6367808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of platelet cross-matching in the management of patients refractory to platelet transfusions.
    Salama OS; Aladl DA; El Ghannam DM; Elderiny WE
    Blood Transfus; 2014 Apr; 12(2):187-94. PubMed ID: 24931840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro tests for platelet compatibility.
    Cook LO; Miller WV
    Vox Sang; 1981 Apr; 40(4):247-52. PubMed ID: 7020241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A real-life evaluation of two platelet cross-matching programmes for the treatment of patients refractory to platelet transfusions.
    Revelli N; Villa MA; Olivero B; Bresciani S; Flores M; Marini M; Pizzi MN; Prati D; Rebulla P
    Vox Sang; 2019 Jan; 114(1):73-78. PubMed ID: 30523641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lymphocytotoxicity and staph-protein A assays in platelet donor selection.
    Bonacossa IA; Perchotte MR; Olchowecki JK; Schroeder ML
    Curr Stud Hematol Blood Transfus; 1986; (52):58-64. PubMed ID: 3698686
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.
    Brand A; van Leeuwen A; Eernisse JG; van Rood JJ
    Blood; 1978 May; 51(5):781-8. PubMed ID: 346088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretic and practical aspects of platelet crossmatching.
    von dem Borne AE; Ouwehand WH; Kuijpers RW
    Transfus Med Rev; 1990 Oct; 4(4):265-78. PubMed ID: 2134633
    [No Abstract]   [Full Text] [Related]  

  • 17. [Selection of HLA compatible donors for patients with HLA antibodies].
    Májský A; Korínková P; Kubícková Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):937-43. PubMed ID: 2419224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
    Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of enzyme-linked immunoassay platelet crossmatching for transfusion of platelet concentrates to alloimmunized recipients.
    Brubaker DB; Duke JC; Romine M
    Am J Hematol; 1987 Apr; 24(4):375-87. PubMed ID: 3551590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion: automated selection of donors.
    Muller JY; Cartron JP; Trillot P; Halle L; Roquin H
    Transfusion; 1981; 21(3):261-7. PubMed ID: 7233510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.